Trial intelligence / Profile preview

MicroRNA in Everolimus vs Tacrolimus for Kidney Transplant

NCT02091973Unknown

Sponsor
Chulalongkorn University
Start
Jun 2010
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of everolimus in kidney transplant rejection (2 arms), sponsored by Chulalongkorn University. Primary endpoint: microRNA profiles at 5 years. Status: unknown.

02

Drugs

everolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT02091973.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02091973.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call